Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters
Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOV0dqMWtESjYyck5UMktyX3E1S3Q4cWVHR2UtZWVKYmpHLW0xREpuWThOOUFtcVcwMGx6ZG9nOG14MXBBQmVTOFl4T0V4XzkzU3ZMSlhJd2VpeWNFU1pGWXJGZTkxelRMcGl5Wko0cjc5TkhrUm5PUnBVNVdwUTRRc0FyY1dqVDZHQXhFZWV1U243UjlUSXBsajVFeVh5XzJpM1lXMGlwNld1RkdaWk9RUHRyQ0hmOWE3dU5yZlVZUDN0Y0VWSU1hREJwYUVpMVdHSHJqWGV0YTRrNkJPbWptNXdscnZLdw?oc=5" target="_blank">Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Eli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
August 28, 2026 at 06:38 PMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMCompanies face backlash over controversial products and advertisement campaigns - Reuters
Companies face backlash over controversial products and advertisement campaigns Reuters
August 25, 2026 at 06:24 PMRoche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PM